Dr. Eleonora Grandi's lab at UC Davis focuses on understanding how atrial fibrillation (AF) affects men and women differently. This research is crucial because women often have worse symptoms and outcomes from AF. The lab uses advanced computational models and experimental techniques to analyze how sex hormones influence heart cell function and arrhythmia risk. Ultimately, the lab aims to develop better treatments that account for these differences.

Dr. Johannes W. Hell's lab focuses on understanding how the Alzheimer’s disease-related protein beta amyloid affects calcium channels in the brain. By studying the Cav1.2 calcium channel, the lab investigates how its dysregulation can lead to neuronal damage and impair synaptic function, which are critical in Alzheimer’s disease. This research opens up new avenues for potential pharmacological interventions to combat the early effects of Alzheimer's.

Dr. Angie Gelli's lab at the University of California, Davis focuses on developing new antifungal treatments to combat serious fungal infections that threaten human health. Using innovative techniques, the lab aims to create and optimize antifungal peptides that can effectively target and destroy fungi while being safe for human cells. The research is critical as we face rising drug resistance in fungal pathogens and aims to create compounds that can save lives.

Yale E. Goldman's lab at UC Davis focuses on understanding how molecular motors and ribosomes function in cells. They study the dynamics of these cellular machines, which are crucial for protein synthesis and transport within cells, using cutting-edge biophysical techniques. Their research aims to uncover mechanisms that contribute to diseases like muscular dystrophy and cystic fibrosis, with the goal of identifying potential therapeutic strategies.

Dr. Donald Bers' lab at UC Davis focuses on understanding the critical molecular mechanisms that lead to heart failure and arrhythmias, which are significant health issues worldwide. They investigate the role of proteins like the cardiac ryanodine receptor and CaMKII, using advanced techniques to explore how these proteins function under normal and pathological conditions. The ultimate goal is to develop new therapeutic strategies targeting these molecular mechanisms to improve heart health.

Dr. Stefano Morotti's lab focuses on understanding heart failure with preserved ejection fraction (HFpEF), a condition affecting many, particularly women. The lab combines experimental and computational techniques to investigate how the disease varies among patients and to identify potential new treatments. By studying the cellular mechanisms behind HFpEF, they aim to develop more effective therapies tailored to different patient profiles.

Professor Manuel F. Navedo's lab at UC Davis focuses on understanding the mechanisms behind vascular smooth muscle dysfunction related to diabetes and heart failure. The research particularly investigates how pressure influences calcium channels in blood vessels and how this process can affect blood flow and blood pressure in health and disease. By exploring these mechanisms, the lab aims to identify new potential treatments for vascular complications associated with lifestyle-related diseases.

Dr. Kevin Xiang Yang's lab at UC Davis focuses on understanding the molecular mechanisms behind heart failure and memory processes in the brain. The lab investigates how receptors and enzymes, such as adrenergic receptors and phosphodiesterases, influence cardiac function and the signaling pathways that regulate gene expression in neurons. The research aims to discover new therapeutic targets that could enhance heart function in heart failure and improve cognitive disorders.

Dr. Ye Chen-Izu's lab at UC Davis focuses on understanding how mechanical forces affect the heart's function and its diseases. The lab investigates how heart muscle cells communicate with each other during contractions, particularly under stress from mechanical loading. By learning how these mechanisms work, the research aims to identify new treatments for heart conditions such as arrhythmias and heart failure, especially those triggered by high blood pressure.